Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum β-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients

Burns

Volumn 36, Issue 1, 2010, Pages 70-74

  Mirsalehian, Akbar ^a   Feizabadi, Mehdi ^a   Nakhjavani, Farrokh A ^a   Jabalameli, Fereshteh ^a   Goli, Hamidreza ^a   Kalantari, Narges ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Burn patients; ESBL; Pseudomonas aeruginosa

Indexed keywords

AZTREONAM; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BURN PATIENT; CONTROLLED STUDY; DISK DIFFUSION; GENE AMPLIFICATION; GENE IDENTIFICATION; GENOTYPE; HUMAN; IRAN; MULTIDRUG RESISTANCE; NONHUMAN; OXA 10 GENE; PER 1 GENE; POLYMERASE CHAIN REACTION; PREVALENCE; PSEUDOMONAS AERUGINOSA; VEB1 GENE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BURN UNITS; BURNS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; WOUND INFECTION;

EID: 72049123989     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2009.01.015     Document Type: Article

References (25)

1. Jiang X., Zhang Z., Li M., Zhou D., Ruan F., and Lu Y. Detection of extended-spectrum β-lactamases in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 50 (2006) 2990-2995
2. Japoni A., Alborzi A., Kalani M., Nasiri J., Hayati M., and Farshad S. Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the south of Iran. Burns 32 (2006) 343-347
3. Cavallo J.D., Fabre R., Leblanc F., Nicolas-Chanoine M.H., and Thabaut A. Antibiotic susceptibility and mechanisms of (-lactam resistance in 1310 strains of Pseudomonas aeruginosa: a French multicentre study (1996). J Antimicrob Chemother 46 (2000) 133-136
4. Weldhagen G.F., Poirel L., and Nordmann P. Ambler Class A extended-spectrum β-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agent Chemother 47 (2003) 2385-2392
5. Lee S., Park Y.J., Kim M., Lee H.K., Han K., Kang C.S., et al. Prevalence of Ambler class A and D β-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother 56 (2005) 122-127
6. Endimiani A., Luzzaro F., Pini B., Amicosante G., Rossolini G.M., and Toniolo A.Q. Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase. BMC Infect Dis 6 (2006) 52
7. Yan J.J., Tsai S.H., Chuang C.L., and Wu J.J. OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan. J Microbiol Immunol Infect 39 (2006) 130-134
8. Bert F., Branger C., and Lambert-Zechovsky N. Identification of PSE and OXA β-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J Antimicrob Chemother 50 (2002) 11-18
9. Aubert D., Poirel L., Chevalier J., Leotard S., Pages J.M., and Nordmann P. Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa. Antimicrob Agents Chemother 45 (2001) 1615-1620
10. Rastegar Lari A., Bahrami Honar H., and Alaghehbandan R. Pseudomonas infections in Tohid Burn Center, Iran. Burns 24 (1998) 637-641
11. Clinical and Laboratory Standards Institute. Performance standards for Antimicrobial susceptibility Testing: Document M10-S15. Wayne, PA, USA: CLSI; 2005.
12. Nikbin V.S., Abdi-Ali A., Feizabadi M.M., and Gharavi S. Pulsed field gel electrophoresis & plasmid profile of Pseudomonas aeruginosa at two hospitals in Tehran, Iran. Indian J Med Res 126 (2007) 146-151
13. Paj H., Kim J., Kim J., Lee J.H., Choe K.W., and Gotoh N. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents and Chemother 45 (2001) 480-484
14. PER-2 β-lactamase genes in clinical isolates from Bolivian hospitals. J Antimicrob Chemother 57 (2006) 975-978
15. Chayakulkeeree M., Junsriwong P., Keerasuntonpong A., Tribuddharat C., and Thamlikitkul. Epidemiology of extended-spectrum beta-lactamase producing Gram-negative Bacilli at Sriraj Hospital, Thailand, 2003. Southeast Asia J Tropic Med Public Health 36 (2005) 1503-1509
16. Kaushik R., Kumar S., Sharma R., and Lal P. Bacteriology of burn wounds - the first three years in a new burn unit at the medical college Chandigarh. Burns 27 (2001) 595-597
17. Song W., Lee K.M., Kang H.J., Shin D.H., and Kim D.K. Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea. Burns 27 (2001) 136-139
18. Ozumba U.C., and Jiburum B.C. Bacteriology of burn wounds in Enugu, Nigeria. Burns 26 (2000) 178-180
19. Tsakris A., Vatopoulos A.C., Tzouvelekis L.S., and Legakis N.J. Diversity of resistant phenotype and plasmid analysis in multi-resistant O: 12 Pseudomonas aeruginosa. Eur J Epidemiol 8 (1992) 865-870
20. Tokarska E, Budak A, Skalkowska E, Karczewska E. Characteristics of resistant phenotypes of Pseudomonas aeruginosa hospital strains. In: 13th ECCMID 2003, Abstract No. P1538.
21. Chanawong A., M'Zali F.H., Heritage J., Lulitanond A., Hawkey P.M., SHV-12, et al. VEB-1 extended-spectrum β-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand. J Antimicrob Chemother 48 (2001) 839-852
22. de Macedo J.L., and Santos J.B. Bacterial and fungal colonization of burn wounds. Mem Inst Oswaldo Cruz 100 5 (2005) 535-539
23. Vahaboglu H., Ozturk R., Akbal H., Saribas S., Tansel O., and Coskunkan F. Practical approach for detection and identification of OXA-10-derived ceftazidime-hydrolyzing extended-spectrum β-lactamases. J Clinical Microbiol 36 (1998) 827-829
24. VEB Gene from a Pseudomonas aeruginosa isolate obtained in India. Antimicrob Agents Chemother 48 (2004) 3284-3290
25. Daniel F., Hall L.M.C., and Livermore D.M. Laboratory mutants of OXA-10 β-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa. J Antimicrob Chemother 43 (1999) 339-344